Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 50 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 62% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $654,033 and 42, calls, for a total amount of $1,889,465.
Latest Startup Investment Opportunities:
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $660.0 for Eli Lilly during the past quarter.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $200.0 to $660.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | PUT | TRADE | BEARISH | 01/16/26 | $600.00 | $375.4K | 189 | 50 |
| LLY | CALL | TRADE | BEARISH | 02/16/24 | $650.00 | $149.2K | 1.2K | 78 |
| LLY | CALL | TRADE | BEARISH | 02/16/24 | $500.00 | $130.0K | 77 | 10 |
| LLY | CALL | SWEEP | BULLISH | 02/16/24 | $650.00 | $88.3K | 1.2K | 198 |
| LLY | PUT | TRADE | BULLISH | 07/19/24 | $620.00 | $87.2K | 22 | 24 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Having examined the options trading patterns of Eli Lilly, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Eli Lilly's Current Market Status
- Trading volume stands at 1,153,782, with LLY's price up by 0.43%, positioned at $628.2.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 27 days.
What The Experts Say On Eli Lilly
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $610.0.
- Reflecting concerns, an analyst from Daiwa Capital lowers its rating to Outperform with a new price target of $610.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
